SANTA CLARA, California, August 31, 2026, 14:31 EDT
- Shares of Oklo increased by 0.8% to reach $40.44 as of 14:02 EDT.
- The most recent reported insider sale involved 3,264 shares, valued at $129,811.
- As of June 30, Oklo reported cash and marketable securities totaling $3.01 billion.
- The company’s approximately $7.5 billion valuation continues to depend on the rollout of future reactors.
Shares of Oklo Inc. NYSE: OKLO gained 0.8% to $40.44 by 14:02 EDT. The stock was the fifth most-searched term on U.S. Google Trends, as insider selling drew interest.
Oklo insider-sale pressure map
Prepared: Aug. 31, 2026, 14:31 EDT
Valuation bridge
Insider sale scale
| Shares sold | 3,264 |
| Execution price | $39.77 |
| Sale value | $129,811 |
| Direct shares retained | 7,822 |
| Joint-account shares | 5,000 |
| Plan adopted | Apr. 2, 2026 |
Financial operating frame
| Metric | Latest | Signal |
|---|---|---|
| Q2 revenue | $1.21M | First revenue |
| Q2 operating loss | -$73.19M | 60× revenue |
| H1 operating cash use | -$65.46M | 2.1× prior year |
| 2026 operating cash guide | $120M-$150M | Funded |
| 2026 capex guide | $400M-$500M | Build phase |
Expectation range
| Low | $51.00 | +26% |
| Average | $74.75 | +85% |
| High | $100.00 | +147% |
| Ratings | 7 Buy · 7 Hold · 0 Sell | |
The most recent public sale was minor compared to Oklo’s valuation. General Counsel Vivek Narayanadas offloaded 3,264 shares for $39.77 each, totaling $129,811. This represents roughly 0.0017% of Oklo’s estimated $7.5 billion market capitalisation.
| Market measure | Latest reading | Investor context |
|---|---|---|
| Share price | $40.44 at 14:02 EDT | Gained 0.75% Monday |
| Friday close | $40.14 | Fell 5.62% August 28 |
| Monday range | $39.50-$40.95 | Most recent intraday range |
| Volume | 3.40 million | As of the 14:02 update |
| Estimated market value | $7.52 billion | Derived from price and 186.02 million shares |
The SEC filing indicates the transaction occurred after an option exercise. It notes the sale took place under a Rule 10b5-1 trading plan. The plan was set up on April 2, several months in advance of the transaction.
The difference is significant. Scheduled sales reveal less about timing compared to discretionary trades on the open market. Narayanadas kept 7,822 shares in his own name and an additional 5,000 via a joint account.
| Latest reported transaction | Shares | Price | Estimated value | Structure |
|---|---|---|---|---|
| Vivek Narayanadas, Aug. 24 | 3,264 | $39.77 | $129,811 | 10b5-1 sale |
| Jacob DeWitte, Aug. 3 | 40,000 | $41.68 | $1.67 million | 10b5-1 sale |
| Caroline Cochran, Aug. 3 | 40,000 | $41.35 | $1.65 million | 10b5-1 sale |
| Caroline Cochran, Aug. 3 | 7,151 | $40.94 | $292,765 | 10b5-1 sale |
Oklo’s finances remain the key investor focus. In its second-quarter report, the company listed $3.006 billion in cash and marketable debt securities. That represents roughly 40% of its present equity value.
Most of the cash was secured via equity issuance. Inflow from financing activities totaled $1.85 billion in the first six months. Oklo stated it remains in the process of assessing further capital raising at both the corporate and asset levels.
| Operating measure | Q2/H1 2026 | Comparison or implication |
|---|---|---|
| Quarterly revenue | $1.21 million | Initial revenue disclosed |
| Q2 operating loss | $73.19 million | Roughly 60 times greater than revenue for the period |
| Q2 net loss | $48.54 million | $0.28 per share |
| H1 operating cash use | $65.46 million | Increased from $30.71 million |
| Cash and securities | $3.006 billion | Represents about 40% of market valuation |
| 2026 planned operating cash use | $120-$150 million | Guidance from company |
| 2026 planned capital spending | $400-$500 million | Guidance from company |
Initial revenue alone does not currently justify the valuation. Investors are basing their assessments on anticipated electricity, isotope and fuel-cycle earnings. Excluding cash and securities, the market values this execution potential at approximately $4.5 billion.
Indicators of operations have advanced. Oklo announced that its Groves isotope test reactor achieved initial criticality on August 6, delivering additional operational insights. However, it still does not represent a full-scale commercial Aurora power facility.
Analyst forecasts are divided. According to the most recent Google Finance summary, there are seven buy ratings and seven hold recommendations. Target prices range between $51 and $100, with the mean estimate from 14 analysts at $74.75.
| Analyst reference | Rating | Target | Distance from $40.44 |
|---|---|---|---|
| Truist | Hold | $51.00 | +26% |
| Citi | Hold | $57.50 | +42% |
| Bank of America | Buy | $80.00 | +98% |
| H.C. Wainwright | Buy | $90.00 | +123% |
| Canaccord Genuity | Buy | $100.00 | +147% |
The stock is valued based on anticipated milestones rather than present earnings. The insider sale is both transparent and confirmable. However, its scale remains small in comparison to Oklo’s liquidity and the funds the company has previously secured.
Risks: Oklo does not currently operate a commercial power plant. Licensing processes, fuel availability, construction expenses and timelines remain subject to change. Additional stock offerings could reduce the value for existing shareholders, while delays may weigh on a valuation dependent on future returns.
Related articles: NYSE:OKLO
